Projects & Grants
| Safe administration of modern immunotherapy in an outpatient setting while using telemedicine and home adverse event monitoring | |
|---|---|
| Project Id | SGS17/LF/2026 |
| Main solver | MUDr. Tereza Popková |
| Period | 1/2026 - 12/2026 |
| Provider | Specifický VŠ výzkum |
| State | solved |
| Anotation | Modern immunotherapy including bispecific antibodies is an extremely effective treatment for hematological malignancies. There is a couple of agents of this type reimbursed for the treatment of multiple myeloma and lymphoma. The treatment is initiated by a step-up phase administered inpatient which transplates into a significant burden for the hospital as well as the patient. Worldwide, the number of bispecific antibody treatment performed outpatient has been increasing recently. The aim of this project is to set up a safe ramp-up phase of bispecific antibody treatment outpatient. |
| Total Costs | 243 931 CZK |
